Our Founding Thesis
The scientific, cultural, and economic drivers that created the human longevity industry are now converging with even greater force in the pet care market.
"Every pet deserves the chance to live their fullest life. Our role is to make that possible through science, compassion, and partnership with their families."
The Paradigm Shift
We are witnessing a fundamental transformation in how society views pet healthcare, moving from reactive "sick care" to proactive "healthspan optimization."
Technological Maturity
The cost of our comprehensive assessment has dropped from £10,000 to £1,495 in just 5 years.
Cultural Priming
Concepts like "biohacking" and "healthspan" have entered mainstream consciousness.
Why This Market, Why Now?
Economic Viability
Pet insurance grew 21.4% YoY to $4.74B in 2024.
62.4%
US households own pets
Competitive Vacuum
No established integrated leader - a 24-36 month window of opportunity.
70%
Vets using integrated telehealth
Gen Z Leading Spend
Gen Z spends $178/month on pets vs Boomers at $90.
34%
Millennials in debt for pets
Health Spending Surge
Health expenses are 19-45.5% of total dog costs.
30%
Avoided vet due to cost in 2024
A Perfect Storm of Opportunity
Multiple converging forces create an ideal environment for rapid growth and category leadership.
$150.6B
US Pet Market 2024
111%
Vet Care Growth Since 2018
$2.4B
Telehealth Market 2034
🛡️ The Economic Moat of Pet Spending
| Economic Event | Overall Consumer Spending | Pet Care Spending |
|---|---|---|
| 2008 Financial Crisis | -3.7% | +5.2% |
| COVID-19 Pandemic | -6.8% | +27% |
| 2023-2024 Inflation | Trading down | Vet +6.7% YoY |
A Vertically Integrated Ecosystem
We've architected a multi-modal healthspan ecosystem that creates compounding competitive advantages.
Pillar 1: Clinical Services
The Foundation
- High-trust client acquisition
- Premium data collection
- £1,495 assessments (65% gross margin)
- EBITDA positive within 12-18 months
Pillar 2: Digital Platform
The Scaler
- Virtual health coaching
- B2B SaaS platform (95% margins)
- 85%+ retention rates
- AI continuously improves
Pillar 3: Data-Driven Products
The Multiplier
- Formulations based on actual needs
- 80%+ gross margins
- Built-in distribution channel
- "Developed from data of 10,000 pets"
The Pawsitive Intelligence™ Data Flywheel
Our Compounding Competitive Advantage
- 1.Acquire Data: Each PLA collects 50GB of multi-omic data per pet.
- 2.Generate Insights: ML models predict disease risk with 89% accuracy.
- 3.Improve Outcomes: Better predictions lead to better protocols.
- 4.Drive Growth: Superior results attract more clients, feeding more data.
A competitor starting today would need £1.5M+ and 18 months just to reach our current capabilities.
World-Class Leadership
Proven builders with direct experience in longevity science and healthcare innovation.
Luis Medeiros
CMO & Co-Founder
Led growth strategy and marketing for 3 scale-ups. Founded and built a hotel business to $1.5M revenue.
Antonia Schultze-Mosgau
COO & Co-Founder
President of Oxford Society for Ageing and Longevity. Neuroeconomist expert.
Dr. Ewa Kania
CSO & Co-Founder
Pioneer in regenerative medicine with a PhD in Stem Cells from King's College London.
Avi Roy
CIO & Co-Founder
President of Biogerontology Research Foundation, Oxford scientist. Expert in computational biology.
Stephen Watson
Longevity Lead & Advisor
Led Founders Health to global expansion. Expert in building tech-enabled health ecosystems.
From Concept to Revenue in 18 Months
We've validated product-market fit with exceptional results and built a proven scaling engine.
$38.3B
US Vet Care Spending
94%
Client Satisfaction
500+
Qualified Waiting List
72
NPS Score
Built for Venture-Scale Returns
A model combining premium service margins with scalable technology economics.
5-Year Revenue Forecast
| Metric | Year 1 | Year 3 | Year 5 |
|---|---|---|---|
| Revenue | £2.5M | £18.0M | £65.0M |
| Gross Margin | 64% | 68% | 72% |
| EBITDA | (£0.5M) | £3.5M | £18.2M |
The £2M Seed Round Opportunity
We're actively seeking qualified seed investors to join us in building the category-defining platform with a clear path to a £300M+ exit in 5-7 years. Market validation completes Q4 2025, with full launch in Q1 2026.
Seed Investment Terms
- Round Size:
- £2,000,000
- Pre-Money Valuation:
- £8,000,000
- Investor Ownership:
- 20%
- Lead Investor:
- Board seat reserved
Use of Funds
Join Us in Defining the Future
This is more than an investment - it's an opportunity to transform how the world cares for its 1 billion companion animals.